Essex, United Kingdom

Kevin James Doyle

USPTO Granted Patents = 23 


 

Average Co-Inventor Count = 6.3

ph-index = 6

Forward Citations = 142(Granted Patents)


Location History:

  • Bicester, Bicester, Oxfordshire OX263WE, GB (2005)
  • Saffron Walden, GB (2012 - 2020)
  • Essex, GB (2016 - 2024)

Company Filing History:


Years Active: 2005-2024

Loading Chart...
Loading Chart...
Loading Chart...
23 patents (USPTO):

Title: Kevin James Doyle: Innovator in Pharmaceutical Chemistry

Introduction

Kevin James Doyle is a distinguished inventor based in Essex, GB, known for his significant contributions to pharmaceutical chemistry. With a remarkable portfolio of 23 patents, Doyle has made strides in developing innovative compounds aimed at treating various clinical conditions.

Latest Patents

Among his latest patents are compounds such as certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides, which serve as dipeptidyl peptidase 1 inhibitors. These compounds are designed to inhibit DPP1 activity, showcasing their potential utility in treating and preventing respiratory diseases, including asthma and chronic obstructive pulmonary disease (COPD). The patents detail their therapeutic applications, pharmaceutical compositions, and processes for preparation.

Career Highlights

Doyle has had a notable career, working with prominent organizations such as AstraZeneca and the Institute for OneWorld Health. His work in these institutions has allowed him to focus on innovative solutions in the pharmaceutical field, contributing to advancements in medical treatments.

Collaborations

Throughout his career, Doyle has collaborated with esteemed colleagues, including Graham Peter Jones and Stephen Connolly. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking pharmaceutical innovations.

Conclusion

Kevin James Doyle's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to impact the treatment of respiratory diseases, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…